BIOS Capital Management, LP

CIK

1813845

Location

Fort Worth, TX

Portfolio Value

Micro $52,866,301

Diversification

Highly concentrated

Filing Date

Global Rank

#6,405 / 8,232 ▼ 408

Top Industry

Biotechnology 100.0%

3Y Alpha vs SPY

-60.4%

Period ended 2 months ago

Filed May 13, 2026 · 32d

6 quarters · since Dec 2024

Clone Performance

Feb 2025–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio

-52.8%

SPY

+23.4%

Annualised alpha

-60.4%

Max drawdown

−68.7%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

6 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

52.1%

−22.4 pts

Top 5

99.5%

+0.2 pts

Top 10

100.0%

0.0 pts

HHI

3,822

Highly concentrated−1,916

Portfolio Trend

6 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$52,866,301	6

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

1 positions

Ticker	Company	Δ Shares	Shares	Value	Open
RNTX	Rein Therapeutics, Inc.	+291,624	1,982,375	$2,577,087
No positions match the current search.

Trimmed

Positions the filer reduced

2 positions

Ticker	Company	Δ Shares	Shares	Value
LTRN	Lantern Pharma Inc.	−145,072	864,435	$1,184,275
INAB	In8bio, Inc.	−85,612	167,805	$248,351
No positions match the current search.

New Positions

Positions the filer opened this quarter

No qualifying positions this quarter.

Sold Out

Positions the filer fully exited

No qualifying positions this quarter.

Portfolio Positions

Compact Export CSV View 13F filing

6 positions · $52,866,301 total · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
INAB	In8bio, Inc. Healthcare	Reduced	167,805	-85,612	$248,351	−58.1%	0.47%
LTRN	Lantern Pharma Inc. Healthcare	Reduced	864,435	-145,072	$1,184,275	−61.3%	2.24%
RNTX	Rein Therapeutics, Inc. Healthcare	Added	1,982,375	+291,624	$2,577,087	+31.4%	4.87%
CGTX	Cognition Therapeutics Inc Healthcare	Held	6,000,000	0	$4,559,999	−43.7%	8.63%
IRD	Opus Genetics, Inc. Healthcare	Held	3,683,429	0	$16,759,601	+126.4%	31.70%
ACTU	Actuate Therapeutics, Inc. Healthcare	Held	10,049,996	0	$27,536,988	−55.2%	52.09%